Related Experiment Video
Updated: Jun 27, 2026

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses
Published on: February 27, 2026
Special Issue "Novel Approaches to Potential COVID-19 Molecular Therapeutics"
Monica Gelzo1,2, Felice Amato1,2, Ivan Gentile3
1Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Naples, Italy.
Abstract:
Several years after its emergence, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [...].
Insights
This study examines coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It provides insights into the ongoing impact and characteristics of the COVID-19 pandemic.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged several years ago, causing the ongoing COVID-19 pandemic.
- Understanding the virus and its effects remains critical for global health strategies.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Single Nucleotide Polymorphisms-SNPs
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibitors of Viral Protein Synthesis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
